{"database": "open_comments", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and document_type = \"Notice\" sorted by comment_end_date descending", "rows": [["FDA-2026-N-0131-0001", "FDA", "FDA-2026-N-0131", "FDA Rare Disease Innovation Hub Future Programming; Request for Comments", "Notice", "Request for Comments", "2026-01-30", 2026, 1, "2026-01-30", "2027-01-01", "2026-03-22 09:00:09", "2026-01903", 1, 0, "09000064b91893ee"], ["FDA-2016-D-1280-0005", "FDA", "FDA-2016-D-1280", "Electronic Submission of Postmarketing Individual Case Safety Reports to the Food and Drug Administration Adverse Event Monitoring System Using International\nCouncil of Harmonisation E2B(R3) Data Standards; Regional Data Elements and Implementation Schedule", "Notice", "Announcement", "2026-04-06", 2026, 4, "2026-04-06", "2026-10-02", "2026-04-07 09:00:25", "2026-06660", 1, 0, "09000064b9253dbc"], ["FDA-2025-E-2426-0006", "FDA", "FDA-2025-E-2426", "Determination of Regulatory Review Period for Purposes of Patent Extension; BLUJEPA", "Notice", "Determinations", "2026-02-13", 2026, 2, "2026-02-13", "2026-08-13", "2026-02-13 20:03:13", "2026-02901", 1, 0, "09000064b91aa6fb"], ["FDA-2025-E-0152-0006", "FDA", "FDA-2025-E-0152", "Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY", "Notice", "Determinations", "2026-02-06", 2026, 2, "2026-02-06", "2026-08-06", "2026-02-06 20:05:43", "2026-02388", 1, 0, "09000064b919467e"], ["FDA-2025-E-0153-0006", "FDA", "FDA-2025-E-0153", "Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY", "Notice", "Determinations", "2026-02-06", 2026, 2, "2026-02-06", "2026-08-06", "2026-02-06 20:06:34", "2026-02388", 1, 0, "09000064b919467f"], ["FDA-2024-E-3539-0006", "FDA", "FDA-2024-E-3539", "Determination of Regulatory Review Period for Purposes of Patent Extension; BEQVEZ", "Notice", "Determinations", "2026-02-06", 2026, 2, "2026-02-06", "2026-08-06", "2026-02-14 13:19:52", "2026-02387", 1, 0, "09000064b9195b4d"], ["FDA-2025-E-0154-0006", "FDA", "FDA-2025-E-0154", "Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY", "Notice", "Determinations", "2026-02-06", 2026, 2, "2026-02-06", "2026-08-06", "2026-02-06 20:07:01", "2026-02388", 1, 0, "09000064b9195c17"], ["FDA-2026-N-3273-0001", "FDA", "FDA-2026-N-3273", "Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments; Public Meeting; Request for Comments", "Notice", "Request for Comments", "2026-04-15", 2026, 4, "2026-04-15", "2026-07-24", "2026-04-15 17:05:22", "2026-07248", 1, 0, "09000064b9282224"], ["FDA-2023-N-0119-0020", "FDA", "FDA-2023-N-0119", "Fiscal Year 2026 Generic Drug Science and Research Initiatives Workshop; Public Workshop; Request for\nComments", "Notice", "Request for Comments", "2026-02-27", 2026, 2, "2026-02-27", "2026-07-11", "2026-04-14 09:00:18", "2026-03961", 1, 0, "09000064b91e326c"], ["FDA-2026-N-2366-0001", "FDA", "FDA-2026-N-2366", "Commissioner\u2019s National Priority Voucher (CNPV) Pilot Program; Public Hearing; Request for Comments", "Notice", "Request for Comments", "2026-03-23", 2026, 3, "2026-03-23", "2026-06-30", "2026-04-12 09:00:14", "2026-05573", 1, 0, "09000064b922c21a"], ["FDA-2026-N-2742-0001", "FDA", "FDA-2026-N-2742", "Agency Information Collection Activities; Proposed Collection; Comment Request; Color Additive Certification", "Notice", "60 Day Proposed Information Collection", "2026-04-10", 2026, 4, "2026-04-10", "2026-06-10", "2026-04-10 18:01:37", "2026-06936", 1, 0, "09000064b926825a"], ["FDA-2026-N-2743-0001", "FDA", "FDA-2026-N-2743", "Agency Information Collection Activities; Proposed Collection; Comment Request; Submission of Petitions: Food Additive, Color Additive (Including Labeling), Submission of Information to a Master File in Support of Petitions; and Electronic Submission Using Food and Drug Administration Form 3503", "Notice", "60 Day Proposed Information Collection", "2026-04-10", 2026, 4, "2026-04-10", "2026-06-10", "2026-04-10 18:22:24", "2026-06935", 1, 0, "09000064b926821b"], ["FDA-2026-N-2915-0001", "FDA", "FDA-2026-N-2915", "Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Approval of Medical Devices", "Notice", "60 Day Proposed Information Collection", "2026-04-10", 2026, 4, "2026-04-10", "2026-06-10", "2026-04-10 17:47:50", "2026-06906", 1, 0, "09000064b9268328"], ["FDA-2026-N-2431-0001", "FDA", "FDA-2026-N-2431", "Agency Information Collection Activities; Proposed Collection; Comment Request; Administrative Practices and Procedures; Formal Hearings", "Notice", "60 Day Proposed Information Collection", "2026-04-07", 2026, 4, "2026-04-07", "2026-06-09", "2026-04-14 19:40:33", "2026-06719", 1, 0, "09000064b9255485"], ["FDA-2025-E-0863-0006", "FDA", "FDA-2025-E-0863", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:37:03", "2026-06478", 1, 0, "09000064b924cccb"], ["FDA-2025-E-0845-0006", "FDA", "FDA-2025-E-0845", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:34:01", "2026-06478", 1, 0, "09000064b924dac3"], ["FDA-2025-E-0866-0006", "FDA", "FDA-2025-E-0866", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:42:13", "2026-06478", 1, 0, "09000064b924ccce"], ["FDA-2025-E-0372-0005", "FDA", "FDA-2025-E-0372", "Determination of Regulatory Review Period for Purposes of Patent Extension; ZIIHERA", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:52:42", "2026-06476", 1, 0, "09000064b924da88"], ["FDA-2025-E-3074-0006", "FDA", "FDA-2025-E-3074", "Determination of Regulatory Review Period for Purposes of Patent Extension; EMRELIS", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:57:30", "2026-06480", 1, 0, "09000064b924c470"], ["FDA-2025-E-0871-0006", "FDA", "FDA-2025-E-0871", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:49:10", "2026-06478", 1, 0, "09000064b924c46e"], ["FDA-2025-E-3073-0006", "FDA", "FDA-2025-E-3073", "Determination of Regulatory Review Period for Purposes of Patent Extension; EMRELIS", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:55:54", "2026-06480", 1, 0, "09000064b924da86"], ["FDA-2025-E-3626-0006", "FDA", "FDA-2025-E-3626", "Determination of Regulatory Review Period for Purposes of Patent Extension; ENFLONSIA", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:59:57", "2026-06479", 1, 0, "09000064b924d98d"], ["FDA-2025-E-0870-0006", "FDA", "FDA-2025-E-0870", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:48:07", "2026-06478", 1, 0, "09000064b924c46d"], ["FDA-2026-N-2740-0001", "FDA", "FDA-2026-N-2740", "Agency Information Collection Activities; Proposed Collection; Comment Request; Customer/Partner Customer Service Satisfaction Surveys", "Notice", "60 Day Proposed Information Collection", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:29:44", "2026-06482", 1, 0, "09000064b924dac4"], ["FDA-2025-E-0868-0006", "FDA", "FDA-2025-E-0868", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:44:23", "2026-06478", 1, 0, "09000064b924c0e1"], ["FDA-2025-E-0865-0006", "FDA", "FDA-2025-E-0865", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:39:45", "2026-06478", 1, 0, "09000064b924cccd"], ["FDA-2025-E-1672-0007", "FDA", "FDA-2025-E-1672", "Determination of Regulatory Review Period for Purposes of Patent Extension; ENCELTO", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 18:06:28", "2026-06477", 1, 0, "09000064b924d940"], ["FDA-2014-E-2328-0006", "FDA", "FDA-2014-E-2328", "Determination of Regulatory Review Period for Purposes of Patent Extension; INJECTAFER", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 18:09:13", "2026-06483", 1, 0, "09000064b924d4f5"], ["FDA-2025-E-0864-0006", "FDA", "FDA-2025-E-0864", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:38:27", "2026-06478", 1, 0, "09000064b924cccc"], ["FDA-2025-E-0872-0006", "FDA", "FDA-2025-E-0872", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:50:02", "2026-06478", 1, 0, "09000064b924c46f"], ["FDA-2025-E-0867-0006", "FDA", "FDA-2025-E-0867", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:43:31", "2026-06478", 1, 0, "09000064b924c0e0"], ["FDA-2025-E-0158-0006", "FDA", "FDA-2025-E-0158", "Determination of Regulatory Review Period for Purposes of Patent Extension; HYMPAVZI", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 18:04:00", "2026-06481", 1, 0, "09000064b924d942"], ["FDA-2025-E-0869-0006", "FDA", "FDA-2025-E-0869", "Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY", "Notice", "Determinations", "2026-04-03", 2026, 4, "2026-04-03", "2026-06-03", "2026-04-03 17:45:32", "2026-06478", 1, 0, "09000064b924ba07"], ["FDA-2026-N-0809-0001", "FDA", "FDA-2026-N-0809", "Recommendations on Scale-Up and Postapproval Changes Guidances for Industry; Request for Comments", "Notice", "Request for Comments", "2026-03-03", 2026, 3, "2026-03-03", "2026-06-02", "2026-04-13 09:00:28", "2026-04196", 1, 0, "09000064b91ed501"], ["FDA-2026-N-2476-0001", "FDA", "FDA-2026-N-2476", "Advancing the Use of Digital Health Technologies in Clinical Investigations for Drugs and Biological Products;\nRequest for Information and Comments", "Notice", "Request for Comments", "2026-03-31", 2026, 3, "2026-03-31", "2026-06-02", "2026-04-10 09:00:28", "2026-06184", 1, 0, "09000064b92439d6"], ["FDA-2024-E-5140-0006", "FDA", "FDA-2024-E-5140", "Determination of Regulatory Review Period for Purposes of Patent Extension; ENVISION MAMMOGRAPHY PLATFORM", "Notice", "Determinations", "2025-11-24", 2025, 11, "2025-11-24", "2026-05-27", "2026-01-24 13:16:48", "2025-20667", 1, 0, "09000064b908e3f0"], ["FDA-2024-E-5139-0006", "FDA", "FDA-2024-E-5139", "Determination of Regulatory Review Period for Purposes of Patent Extension; ENVISION MAMMOGRAPHY PLATFORM", "Notice", "Determinations", "2025-11-24", 2025, 11, "2025-11-24", "2026-05-27", "2026-01-24 13:16:48", "2025-20667", 1, 0, "09000064b908e3ef"], ["FDA-2024-E-5141-0006", "FDA", "FDA-2024-E-5141", "Determination of Regulatory Review Period for Purposes of Patent Extension; ENVISION MAMMOGRAPHY PLATFORM", "Notice", "Determinations", "2025-11-24", 2025, 11, "2025-11-24", "2026-05-27", "2026-01-24 13:16:50", "2025-20667", 1, 0, "09000064b9092f99"], ["FDA-2024-E-5681-0006", "FDA", "FDA-2024-E-5681", "Determination of Regulatory Review Period for Purposes of Patent Extension; ALTIUS DIRECT ELECTRICAL NERVE STIMULATION\nSYSTEM", "Notice", "Determinations", "2025-11-24", 2025, 11, "2025-11-24", "2026-05-27", "2025-11-24 19:32:14", "2025-20668", 1, 0, "09000064b9093521"], ["FDA-2026-N-2365-0001", "FDA", "FDA-2026-N-2365", "Agency Information Collection Activities; Proposed Collection; Comment Request; Reporting Associated With Animal Drug and Animal Generic Drug User Fees", "Notice", "60 Day Proposed Information Collection", "2026-03-23", 2026, 3, "2026-03-23", "2026-05-23", "2026-03-23 17:37:47", "2026-05620", 1, 0, "09000064b922c25e"], ["FDA-2026-N-2364-0001", "FDA", "FDA-2026-N-2364", "Agency Information Collection Activities; Proposed Collection; Comment Request; Food and Drug\nAdministration Advisory Committees", "Notice", "60 Day Proposed Information Collection", "2026-03-23", 2026, 3, "2026-03-23", "2026-05-23", "2026-03-25 09:00:29", "2026-05623", 1, 0, "09000064b922c187"], ["FDA-2026-N-1849-0001", "FDA", "FDA-2026-N-1849", "Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Notifications Submission", "Notice", "60 Day Proposed Information Collection", "2026-03-19", 2026, 3, "2026-03-19", "2026-05-19", "2026-03-19 17:24:48", "2026-05329", 1, 0, "09000064b9224334"], ["FDA-2026-N-2279-0001", "FDA", "FDA-2026-N-2279", "Preparation for International Cooperation on Cosmetics Regulation Twentieth Annual Meeting (ICCR\u201320); Request for Comments", "Notice", "Request for Comments", "2026-03-18", 2026, 3, "2026-03-18", "2026-05-19", "2026-04-03 09:00:22", "2026-05280", 1, 0, "09000064b922165c"], ["FDA-2026-N-1736-0001", "FDA", "FDA-2026-N-1736", "Agency Information Collection Activities; Proposed Collection; Comment Request; Investigational New Drug Application Requirements", "Notice", "60 Day Proposed Information Collection", "2026-03-13", 2026, 3, "2026-03-13", "2026-05-13", "2026-03-13 17:05:05", "2026-04938", 1, 0, "09000064b92145ad"], ["FDA-2025-N-4731-0052", "FDA", "FDA-2025-N-4731", "Increasing Access to Nonprescription Drugs; Public Meeting; Request for Comments", "Notice", "Request for Comments", "2026-04-15", 2026, 4, "2026-04-15", "2026-05-09", "2026-04-15 17:08:45", "2026-07335", 1, 0, "09000064b9282192"], ["FDA-2025-E-0493-0006", "FDA", "FDA-2025-E-0493", "Determination of Regulatory Review Period for Purposes of Patent Extension; ENSACOVE", "Notice", "Determinations", "2026-03-06", 2026, 3, "2026-03-06", "2026-05-06", "2026-03-06 19:06:30", "2026-04491", 1, 0, "09000064b91f8458"], ["FDA-2026-N-2741-0001", "FDA", "FDA-2026-N-2741", "Consideration of Acceptable Market Name Change for Certain Rockfish (Sebastes spp.); Request for Information", "Notice", "Requests for Information (RFI)", "2026-04-01", 2026, 4, "2026-04-01", "2026-05-02", "2026-04-14 19:40:35", "2026-06294", 1, 0, "09000064b924995a"], ["FDA-2026-N-1867-0001", "FDA", "FDA-2026-N-1867", "Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments\u2014New Drug Application 220359, for Camizestrant Tablets; Supplemental New Drug Application (sNDA) 218197/S\u2013004, for Truqap (Capivasertib) Tablets", "Notice", "Request for Comments", "2026-03-09", 2026, 3, "2026-03-09", "2026-04-30", "2026-04-16 09:00:12", "2026-04497", 1, 0, "09000064b9200842"], ["FDA-2026-N-0686-0001", "FDA", "FDA-2026-N-0686", "Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements", "Notice", "60 Day Proposed Information Collection", "2026-02-24", 2026, 2, "2026-02-24", "2026-04-28", "2026-02-24 19:45:30", "2026-03589", 1, 0, "09000064b91d5809"], ["FDA-2024-E-3572-0007", "FDA", "FDA-2024-E-3572", "Determination of Regulatory Review Period for Purposes of Patent Extension; TEVIMBRA", "Notice", "Determinations", "2026-02-26", 2026, 2, "2026-02-26", "2026-04-28", "2026-02-26 20:52:55", "2026-03851", 1, 0, "09000064b91deb48"], ["FDA-2025-E-0161-0006", "FDA", "FDA-2025-E-0161", "Determination of Regulatory Review Period for Purposes of Patent Extension; ORLYNVAH", "Notice", "Determinations", "2026-02-26", 2026, 2, "2026-02-26", "2026-04-28", "2026-02-26 20:55:38", "2026-03848", 1, 0, "09000064b91deb09"], ["FDA-2024-E-3565-0006", "FDA", "FDA-2024-E-3565", "Determination of Regulatory Review Period for Purposes of Patent Extension; LIMFLOW SYSTEM", "Notice", "Determinations", "2026-02-26", 2026, 2, "2026-02-26", "2026-04-28", "2026-02-26 20:38:14", "2026-03855", 1, 0, "09000064b91e03ee"], ["FDA-2024-E-3555-0007", "FDA", "FDA-2024-E-3555", "Determination of Regulatory Review Period for Purposes of Patent Extension; LIMFLOW SYSTEM", "Notice", "Determinations", "2026-02-26", 2026, 2, "2026-02-26", "2026-04-28", "2026-02-26 20:35:08", "2026-03855", 1, 0, "09000064b91dec48"], ["FDA-2025-E-1226-0007", "FDA", "FDA-2025-E-1226", "Determination of Regulatory Review Period for Purposes of Patent Extension; AEROPACE", "Notice", "Determinations", "2026-02-26", 2026, 2, "2026-02-26", "2026-04-28", "2026-02-26 20:32:36", "2026-03849", 1, 0, "09000064b91dec81"], ["FDA-2025-E-1229-0006", "FDA", "FDA-2025-E-1229", "Determination of Regulatory Review Period for Purposes of Patent Extension; MERIT MEDICAL WRAPSODY", "Notice", "Determinations", "2026-02-26", 2026, 2, "2026-02-26", "2026-04-28", "2026-02-26 20:43:12", "2026-03853", 1, 0, "09000064b91e03f1"], ["FDA-2025-E-0371-0006", "FDA", "FDA-2025-E-0371", "Determination of Regulatory Review Period for Purposes of Patent Extension; REVUFORJ", "Notice", "Determinations", "2026-02-26", 2026, 2, "2026-02-26", "2026-04-28", "2026-02-26 20:46:51", "2026-03847", 1, 0, "09000064b91dec08"], ["FDA-2024-E-3564-0006", "FDA", "FDA-2024-E-3564", "Determination of Regulatory Review Period for Purposes of Patent Extension; LIMFLOW SYSTEM", "Notice", "Determinations", "2026-02-26", 2026, 2, "2026-02-26", "2026-04-28", "2026-02-26 20:36:56", "2026-03855", 1, 0, "09000064b91e03ed"], ["FDA-2025-E-0500-0006", "FDA", "FDA-2025-E-0500", "Determination of Regulatory Review Period for Purposes of Patent Extension; TRYNGOLZA", "Notice", "Determinations", "2026-02-26", 2026, 2, "2026-02-26", "2026-04-28", "2026-02-26 20:57:25", "2026-03850", 1, 0, "09000064b91deac5"], ["FDA-2025-E-1228-0006", "FDA", "FDA-2025-E-1228", "Determination of Regulatory Review Period for Purposes of Patent Extension; MERIT MEDICAL WRAPSODY", "Notice", "Determinations", "2026-02-26", 2026, 2, "2026-02-26", "2026-04-28", "2026-02-27 10:00:26", "2026-03853", 1, 0, "09000064b91dec45"], ["FDA-2026-N-0027-0001", "FDA", "FDA-2026-N-0027", "Agency Information Collection Activities; Proposed Collection; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing", "Notice", "60 Day Proposed Information Collection", "2026-02-25", 2026, 2, "2026-02-25", "2026-04-28", "2026-02-25 19:16:33", "2026-03773", 1, 0, "09000064b91da53a"], ["FDA-2026-N-0496-0001", "FDA", "FDA-2026-N-0496", "Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice Regulations for Medicated Feeds", "Notice", "60 Day Proposed Information Collection", "2026-02-25", 2026, 2, "2026-02-25", "2026-04-28", "2026-04-03 09:00:19", "2026-03772", 1, 0, "09000064b91da591"], ["FDA-2023-P-3942-1120", "FDA", "FDA-2023-P-3942", "Labeling and Preventing Cross-Contact of Gluten for Packaged Foods; Request for Information", "Notice", "Requests for Information (RFI)", "2026-01-22", 2026, 1, "2026-01-22", "2026-04-23", "2026-04-16 09:00:08", "2026-01121", 1, 0, "09000064b91781b1"], ["FDA-2026-N-0746-0001", "FDA", "FDA-2026-N-0746", "Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice (CGMP): Manufacturing, Processing, Packing, and Holding of Drugs; GMP for\nFinished Pharmaceuticals (Including Active Pharmaceutical Ingredients) and the Advanced Manufacturing\nTechnologies Designation Program", "Notice", "60 Day Proposed Information Collection", "2026-02-20", 2026, 2, "2026-02-20", "2026-04-22", "2026-03-14 09:00:11", "2026-03326", 1, 0, "09000064b91c75af"], ["FDA-2026-N-1305-0001", "FDA", "FDA-2026-N-1305", "Agency Information Collection Activities; Proposed Collection; Comment Request; New Animal Drugs for Minor Use and Minor Species", "Notice", "60 Day Proposed Information Collection", "2026-02-20", 2026, 2, "2026-02-20", "2026-04-22", "2026-04-06 09:00:14", "2026-03353", 1, 0, "09000064b91c750d"], ["FDA-2026-N-0499-0001", "FDA", "FDA-2026-N-0499", "Agency Information Collection Activities; Proposed Collection; Comment Request; Hazard Analysis and Critical Control Point Procedures for the Safe and Sanitary Processing and Importing of Juice", "Notice", "60 Day Proposed Information Collection", "2026-02-20", 2026, 2, "2026-02-20", "2026-04-22", "2026-02-20 20:23:05", "2026-03332", 1, 0, "09000064b91c75b1"], ["FDA-2026-N-1303-0001", "FDA", "FDA-2026-N-1303", "Agency Information Collection Activities; Proposed Collection; Comment Request; Adverse Events Associated With New Animal Drugs", "Notice", "60 Day Proposed Information Collection", "2026-02-20", 2026, 2, "2026-02-20", "2026-04-22", "2026-02-20 20:55:00", "2026-03352", 1, 0, "09000064b91c3035"], ["FDA-2026-N-0684-0001", "FDA", "FDA-2026-N-0684", "Agency Information Collection Activities; Proposed Collection; Comment Request; Approved Organizations for Wholesale Drug Distributors and Third-Party Logistics Providers", "Notice", "60 Day Proposed Information Collection", "2026-02-20", 2026, 2, "2026-02-20", "2026-04-22", "2026-02-20 20:51:55", "2026-03333", 1, 0, "09000064b91c307f"], ["FDA-2026-N-0497-0001", "FDA", "FDA-2026-N-0497", "Agency Information Collection Activities; Proposed Collection; Comment Request; Patent Term Restoration; Due Diligence Petitions; Filing, Format, and Content of Petitions", "Notice", "60 Day Proposed Information Collection", "2026-02-18", 2026, 2, "2026-02-18", "2026-04-21", "2026-02-18 19:12:13", "2026-03094", 1, 0, "09000064b91b8f13"], ["FDA-2026-N-0498-0001", "FDA", "FDA-2026-N-0498", "Agency Information Collection Activities; Proposed Collection; Comment Request; Procedures for the Safe Processing and Importing of Fish and Fishery Products", "Notice", "60 Day Proposed Information Collection", "2026-02-19", 2026, 2, "2026-02-19", "2026-04-21", "2026-02-19 20:20:32", "2026-03311", 1, 0, "09000064b91bd409"], ["FDA-2025-E-0862-0006", "FDA", "FDA-2025-E-0862", "Determination of Regulatory Review Period for Purposes of Patent Extension; SYMVESS", "Notice", "Determinations", "2026-02-19", 2026, 2, "2026-02-19", "2026-04-21", "2026-02-19 20:54:45", "2026-03312", 1, 0, "09000064b91bd33f"]], "truncated": false, "filtered_table_rows_count": 70, "expanded_columns": [], "expandable_columns": [], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 order by comment_end_date desc limit 101", "params": {"p0": "FDA", "p1": "Notice"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/open_comments/documents.json?agency_id=FDA&document_type=Notice", "results": [{"value": "FDA", "label": "FDA", "count": 70, "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?document_type=Notice", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/open_comments/documents.json?agency_id=FDA&document_type=Notice", "results": [{"value": "Notice", "label": "Notice", "count": 70, "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet=posted_date"}, {"name": "posted_year", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet=posted_year"}, {"name": "posted_month", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet=comment_start_date"}, {"name": "comment_end_date", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet=comment_end_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://regs.datadawn.org/open_comments/documents.json?agency_id=FDA&document_type=Notice&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 18.164365086704493, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}